Volker Teichgräaeber

Title: Volker Teichgräaeber: Innovator in Therapeutic Dosage Regimens

Introduction

Volker Teichgräaeber is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of therapeutic agents, particularly in the design of dosage regimens. His work focuses on optimizing treatment protocols for individuals receiving IL-2 receptor-targeted therapies.

Latest Patents

Teichgräaeber holds 1 patent for his invention titled "Materials and methods relating to dosage regimen design." This patent provides innovative materials and methods for determining optimal dosage regimens for therapeutic agents. Specifically, it addresses dosage regimens for agents targeting the IL-2 receptor, with a focus on interleukin 2 (IL2)-based therapies. The methods outlined in his patent allow for the establishment of general dosage regimens for new IL-2R targeted therapeutic agents, as well as tailored regimens for individual patients.

Career Highlights

Volker Teichgräaeber is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to contribute to advancements in therapeutic methodologies and patient care.

Collaborations

Teichgräaeber has collaborated with notable colleagues, including Hans Peter Grimm and Benjamin Ribba. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

Volker Teichgräaeber's innovative approach to dosage regimen design represents a significant advancement in therapeutic treatments. His contributions are poised to improve patient outcomes in the realm of IL-2 receptor-targeted therapies.